{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:48:30Z","timestamp":1782262110797,"version":"3.54.5"},"reference-count":402,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001081","name":"The University of Newcastle Hunter Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jneuroim.2025.578716","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:04:22Z","timestamp":1754665462000},"page":"578716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Immunity in Parkinson's disease \u2013 The role of innate responses"],"prefix":"10.1016","volume":"408","author":[{"given":"A.R. Satvik","family":"Iyengar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Dunkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2025.578716_bb0005","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/mds.23265","article-title":"Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson\u2019s disease","volume":"25","author":"Aasly","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0010","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3934\/Neuroscience.2021031","article-title":"Tumor necrosis factor (TNF) induces astrogliosis, microgliosis and promotes survival of cortical neurons","volume":"8","author":"Abd-El-Basset","year":"2021","journal-title":"AIMS Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.593026","article-title":"Blood-brain barrier leakage is increased in parkinson\u2019s disease","volume":"11","author":"Al-Bachari","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neures.2023.02.001","article-title":"Astrocytes and brain-derived neurotrophic factor (BDNF)","volume":"197","author":"Albini","year":"2023","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0025","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00702-013-1149-z","article-title":"A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease","volume":"121","author":"Ambrosi","year":"2014","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41531-020-00147-6","article-title":"Plasma-borne indicators of inflammasome activity in Parkinson\u2019s disease patients","volume":"7","author":"Anderson","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2025.113825","article-title":"Complement function and activation in human serum and plasma collected in different blood collection tubes","volume":"538","author":"Andersson","year":"2025","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0040","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/jnc.13024","article-title":"Lipid peroxidation is essential for \u03b1-synuclein-induced cell death","volume":"133","author":"Angelova","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0045","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/med.21712","article-title":"Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: finding ways for prevention","volume":"41","author":"Angelova","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0050","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2025.107872","article-title":"Apomorphine: past, present and future in Parkinson's disease and beyond","author":"Auffret","year":"2025","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101904","article-title":"Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE \u03b54, sex and age","volume":"198","author":"Ayton","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0538-2","article-title":"Complement activation at the motor end-plates in amyotrophic lateral sclerosis","volume":"13","author":"Bahia El Idrissi","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0070","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/brain\/awh054","article-title":"The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson\u2019s disease","volume":"127","author":"Bandopadhyay","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-015-0434-1","article-title":"Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit","volume":"12","author":"Banks","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/glia.20015","article-title":"Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure","volume":"46","author":"Barcia","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.17","article-title":"IFN-\u03b3 signaling, with the synergistic contribution of TNF-\u03b1, mediates cell specific microglial and astroglial activation in experimental models of Parkinson\u2019s disease","volume":"2","author":"Barcia","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202400118","article-title":"The history and status of dopamine cell therapies for Parkinson\u2019s disease","volume":"46","author":"Barker","year":"2024","journal-title":"Bioessays"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/10454411950060020301","article-title":"Complement biosynthesis in the central nervous system","volume":"6","author":"Barnum","year":"1995","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.897056","article-title":"GABA receptor agonists protect from excitotoxic damage induced by AMPA in oligodendrocytes","volume":"13","author":"Bay\u00f3n-Cordero","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00401-007-0250-5","article-title":"Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits","volume":"114","author":"Beach","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0110","first-page":"2","article-title":"NSAIDs may protect against age-related brain atrophy","author":"Bendlin","year":"2010","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0115","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1523\/JNEUROSCI.1510-05.2005","article-title":"Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures","volume":"25","author":"Bernardino","year":"2005","journal-title":"J. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2025.578716_bb0120","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.parkreldis.2015.09.028","article-title":"Adaptive deep brain stimulation in Parkinson\u2019s disease","volume":"22","author":"Beudel","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adm8563","article-title":"Microglia-specific <i>IL-10<\/i> gene delivery inhibits neuroinflammation and neurodegeneration in a mouse model of Parkinson&#x2019;s disease","volume":"16","author":"Bido","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0130","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1096\/fj.12-226852","article-title":"Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies","volume":"27","author":"Bisaglia","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0135","first-page":"65","article-title":"An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease","volume":"25","author":"Blandini","year":"2010","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/sni.sni_441_16","article-title":"Parkinson\u2019s disease: Microglial\/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration","volume":"8","author":"Blaylock","year":"2017","journal-title":"Surg. Neurol. Int."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0145","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/845618","article-title":"Classic and new animal models of Parkinson's disease","volume":"2012","author":"Blesa","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson\u2019s disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0155","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","article-title":"The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis","volume":"40","author":"Booth","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0160","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41582-019-0231-z","article-title":"Neuroinflammation in frontotemporal dementia","volume":"15","author":"Bright","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0165","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0170","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","article-title":"Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism","volume":"441","author":"Brodacki","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)01192-5","article-title":"Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss","volume":"823","author":"Brooks","year":"1999","journal-title":"Brain Res."},{"issue":"Suppl. 2","key":"10.1016\/j.jneuroim.2025.578716_bb0180","article-title":"Morphological and functional imaging studies on the diagnosis and progression of Parkinson\u2019s disease","volume":"247","author":"Brooks","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0185","first-page":"705","article-title":"Ultra-micronized palmitoylethanolamide: an efficacious adjuvant therapy for Parkinson's disease","volume":"16","author":"Brotini","year":"2017","journal-title":"CNS Neurol. Disord. - Drug Targets (Form. Curr. Drug Targ. - CNS; Neurol. Disord.)"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0190","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/JLB.2MR0220-549R","article-title":"ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis","volume":"108","author":"Bui","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0195","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00401-007-0303-9","article-title":"Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine","volume":"115","author":"Burke","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0200","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fneur.2019.00122","article-title":"Inflammation, infectious triggers, and Parkinson\u2019s disease","volume":"10","author":"Caggiu","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0205","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0210","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41467-019-08858-y","article-title":"Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis","volume":"10","author":"Carballo-Carbajal","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0215","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fimmu.2019.00362","article-title":"Therapeutic inhibition of the complement system in diseases of the central nervous system","volume":"10","author":"Carpanini","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0220","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1471-4159.2006.03777.x","article-title":"Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline","volume":"97","author":"Casarejos","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0225","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1046\/j.1471-4159.1998.70041584.x","article-title":"Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system","volume":"70","author":"Castano","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/science.abo7649","article-title":"Transforming the understanding of brain immunity","volume":"380","author":"Castellani","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0235","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fneur.2014.00242","article-title":"Presynaptic mechanisms of L-DOPA-Induced dyskinesia: The findings, the debate, and the therapeutic implications","volume":"5","author":"Cenci","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0240","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/1389202914666131210195808","article-title":"Genetic insights into sporadic Parkinson\u2019s disease pathogenesis","volume":"14","author":"Chai","year":"2013","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0245","article-title":"Oxidative Stress and Neuroinflammation in Parkinson's Disease: The Role of Dopamine Oxidation Products","volume":"12","author":"Chakrabarti","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0250","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2009.09.003","article-title":"Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson\u2019s disease","volume":"216","author":"Chao","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0255","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajhg.2011.08.009","article-title":"Translation initiator EIF4G1 mutations in familial Parkinson disease","volume":"89","author":"Chartier-Harlin","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577089","article-title":"Inflammasome and alpha-synuclein in Parkinson's disease: a cross-sectional study","volume":"338","author":"Chatterjee","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0265","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.2008.05697.x","article-title":"Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum","volume":"107","author":"Chen","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0270","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11481-017-9732-y","article-title":"TGF-\u03b21 neuroprotection via Inhibition of microglial activation in a rat model of Parkinson\u2019s disease","volume":"12","author":"Chen","year":"2017","journal-title":"J. Neuroimmunol. Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0275","article-title":"The complement system in the central nervous system: from neurodevelopment to neurodegeneration","volume":"12","author":"Chen","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0280","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0285","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/WNR.0000000000001950","article-title":"Curcumin protects from LPS-induced activation of astrocytes via AMPK pathway","volume":"34","author":"Cheng","year":"2023","journal-title":"Neuroreport"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0290","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: the good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0295","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","article-title":"A progressive mouse model of Parkinson\u2019s disease: the Thy1-aSyn (\u201cLine 61\u201d) mice","volume":"9","author":"Chesselet","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0300","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s13205-025-04267-9","article-title":"Targeting dopaminergic neuronal death: Luteolin as a therapeutic modulator in Parkinson\u2019s disease","volume":"15","author":"Chib","year":"2025","journal-title":"3 Biotech"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0305","doi-asserted-by":"crossref","first-page":"139","DOI":"10.14802\/jmd.19046","article-title":"Modeling \u03b1-Synuclein propagation with preformed fibril injections","volume":"12","author":"Chung","year":"2019","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0310","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/370526","article-title":"MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson\u2019s disease","volume":"2013","author":"Chung","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0315","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/biom9070271","article-title":"Role of Dietary Supplements in the Management of Parkinson\u2019s Disease","volume":"9","author":"Ciulla","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0320","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/stmcls\/sxae042","article-title":"Advancing Parkinson\u2019s disease treatment: cell replacement therapy with neurons derived from pluripotent stem cells","volume":"42","author":"Clark","year":"2024","journal-title":"Stem Cells"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0325","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.3390\/ijms22105305","article-title":"Palmitoylethanolamide: a natural compound for health management","volume":"22","author":"Clayton","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055375","article-title":"Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies","volume":"8","author":"Codolo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0335","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrn3039","article-title":"Ageing as a primary risk factor for Parkinson\u2019s disease: evidence from studies of non-human primates","volume":"12","author":"Collier","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0340","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.it.2016.06.006","article-title":"Astrocytes: key regulators of neuroinflammation","volume":"37","author":"Colombo","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0345","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/antiox9030216","article-title":"An update of palmitoylethanolamide and luteolin effects in preclinical and clinical studies of neuroinflammatory events","volume":"9","author":"Cordaro","year":"2020","journal-title":"Antioxidants"},{"issue":"Pt 8","key":"10.1016\/j.jneuroim.2025.578716_bb0350","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","article-title":"Tyrosine hydroxylase and regulation of dopamine synthesis","volume":"508","author":"Daubner","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0360","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/genes12071006","article-title":"The genetics of Parkinson\u2019s disease and implications for clinical practice","volume":"12","author":"Day","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0365","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/ageing\/24.3.210","article-title":"The levodopa test in Parkinson\u2019s disease","volume":"24","author":"D\u2019Costa","year":"1995","journal-title":"Age Ageing"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0370","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.neubiorev.2021.06.027","article-title":"Interplay between immunity and amyotrophic lateral sclerosis: clinical impact","volume":"127","author":"De Marchi","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0375","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson\u2019s disease: Autoimmunity and neuroinflammation","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0380","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1007\/s00018-013-1352-y","article-title":"The role of inflammation in sporadic and familial Parkinson's disease","volume":"70","author":"Deleidi","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0385","article-title":"Lipopolysaccharide animal models of Parkinson\u2019s disease: recent progress and relevance to clinical disease","volume":"4","author":"Deng","year":"2020","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0390","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0395","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009258","article-title":"Parkinson\u2019s disease and parkinsonism: neuropathology","volume":"2","author":"Dickson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0400","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0405","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/B978-0-12-411512-5.00002-6","article-title":"Tyrosine hydroxylase: regulation by feedback inhibition and phosphorylation","volume":"68","author":"Dickson","year":"2013","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0410","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.4103\/1673-5374.306064","article-title":"Astrocytes: a double-edged sword in neurodegenerative diseases","volume":"16","author":"Ding","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0415","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12974-024-03070-2","article-title":"Hypoxia inducible factor-1\u03b1 regulates microglial innate immune memory and the pathology of Parkinson\u2019s disease","volume":"21","author":"Dong","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0420","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0425","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainres.2014.09.008","article-title":"The role of the immune system in neurodegenerative disorders: adaptive or maladaptive?","volume":"1617","author":"Doty","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0430","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40035-023-00368-8","article-title":"Animal models of Parkinson\u2019s disease: bridging the gap between disease hallmarks and research questions","volume":"12","author":"Dovonou","year":"2023","journal-title":"Translat. Neurodegener."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0435","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/jnc.14675","article-title":"Tyrosine hydroxylase phosphorylation in vivo","volume":"149","author":"Dunkley","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0440","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02797.x","article-title":"Tyrosine hydroxylase phosphorylation: regulation and consequences","volume":"91","author":"Dunkley","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0445","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1472-8206.2008.00616.x","article-title":"The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery","volume":"22","author":"Dutta","year":"2008","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0450","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0455","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0197-4580(96)00108-X","article-title":"The role of complement and activated microglia in the pathogenesis of Alzheimer's disease","volume":"17","author":"Eikelenboom","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102714","article-title":"LPS-induced mitochondrial dysfunction regulates innate immunity activation and \u03b1-synuclein oligomerization in Parkinson\u2019s disease","volume":"63","author":"Esteves","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0465","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00415-016-8052-0","article-title":"Immune-mediated processes in neurodegeneration: where do we stand?","volume":"263","author":"Fakhoury","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105080","article-title":"A1\/A2 astrocytes in central nervous system injuries and diseases: Angels or devils?","volume":"148","author":"Fan","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0475","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12974-019-1670-6","article-title":"Systemic activation of NLRP3 inflammasome and plasma alpha-synuclein levels are correlated with motor severity and progression in Parkinson\u2019s disease","volume":"17","author":"Fan","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"Pt 5","key":"10.1016\/j.jneuroim.2025.578716_bb0480","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0485","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1134\/S1819712419040020","article-title":"Lipid peroxidation products in the blood plasma of patients with Parkinson\u2019s disease as possible biomarkers of different stages of the disease","volume":"13","author":"Fedorova","year":"2019","journal-title":"Neurochem. J."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0490","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0495","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0006-8993(99)01166-X","article-title":"Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase","volume":"823","author":"Ferrante","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0500","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbd.2006.06.013","article-title":"Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra","volume":"24","author":"Ferrari","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0505","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1021\/acschemneuro.6b00231","article-title":"Synthesis, structure characterization, and evaluation in microglia cultures of meuromelanin analogues suitable for modeling Parkinson\u2019s disease","volume":"8","author":"Ferrari","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0510","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1474-4422(15)00336-1","article-title":"Opicapone as an adjunct to levodopa in patients with Parkinson\u2019s disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial","volume":"15","author":"Ferreira","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0515","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-020-00154-7","article-title":"Astrogliosis and sexually dimorphic neurodegeneration and microgliosis in the olfactory bulb in Parkinson's disease","volume":"7","author":"Flores-Cuadrado","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0520","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.4049\/jimmunol.1202533","article-title":"Markers of nonselective and specific NK cell activation","volume":"190","author":"Fogel","year":"2013","journal-title":"J. Immunol."},{"issue":"Suppl. 3","key":"10.1016\/j.jneuroim.2025.578716_bb0525","first-page":"S2","article-title":"The movement disorder society evidence-based medicine review update: treatments for the motor symptoms of Parkinson\u2019s disease","volume":"26","author":"Fox","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0530","doi-asserted-by":"crossref","first-page":"10825","DOI":"10.1523\/JNEUROSCI.3001-08.2008","article-title":"Parkin deficiency increases vulnerability to inflammation-related nigral degeneration","volume":"28","author":"Frank-Cannon","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0535","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1474-4422(14)70266-2","article-title":"CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study","volume":"14","author":"Funayama","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0540","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10286-024-01090-9","article-title":"Effects of levodopa\/carbidopa intestinal gel infusion on autonomic symptoms in advanced Parkinson\u2019s disease: a systematic review","volume":"35","author":"Galli","year":"2025","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0545","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0550","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1523\/JNEUROSCI.3732-10.2011","article-title":"HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration","volume":"31","author":"Gao","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0555","first-page":"12","article-title":"Peripheral inflammation enhances microglia response and nigral dopaminergic cell death in an in vivo MPTP model of Parkinson\u2019s disease","author":"Garc\u00eda-Dom\u00ednguez","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0560","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-8-14","article-title":"Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1\u03b2 and NMDA stimulation","volume":"8","author":"Gardoni","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0565","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.abf7266","article-title":"CD4(+) T cells contribute to neurodegeneration in Lewy body dementia","volume":"374","author":"Gate","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0570","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0575","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00702-025-02901-7","article-title":"Nutritional and dietary clinical trials for Parkinson's disease: a narrative review","volume":"132","author":"Giannakis","year":"2025","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0580","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0585","doi-asserted-by":"crossref","first-page":"18738","DOI":"10.1074\/jbc.M111.311589","article-title":"Dopamine-derived quinones affect the structure of the redox sensor DJ-1 through modifications at Cys-106 and Cys-53","volume":"287","author":"Girotto","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0590","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0595","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.726421","article-title":"Microglia and perivascular macrophages act as antigen presenting cells to promote CD8 T cell infiltration of the brain","volume":"12","author":"Goddery","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0600","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41531-021-00201-x","article-title":"TNFalpha increases tyrosine hydroxylase expression in human monocytes","volume":"7","author":"Gopinath","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0605","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.imbio.2016.06.146","article-title":"Complement C5a activates microglial NLRP3 inflammasomes and drives neurodegeneration in Parkinson\u2019s disease through C5aR1","volume":"221","author":"Gordon","year":"2016","journal-title":"Immunobiol"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0610","first-page":"10","article-title":"Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice","author":"Gordon","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0615","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.bbamcr.2009.10.001","article-title":"Differential regulation of human tyrosine hydroxylase isoforms 1 and 2 in situ: isoform 2 is not phosphorylated at Ser35","volume":"1793","author":"Gordon","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0620","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23619","article-title":"Luteolin: nature's promising warrior against Alzheimer's and Parkinson's disease","volume":"38","author":"Goyal","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0625","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0006-8993(94)90883-4","article-title":"TNF-alpha increases the frequency of spontaneous miniature synaptic currents in cultured rat hippocampal neurons","volume":"659","author":"Grassi","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0630","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12974-021-02225-9","article-title":"Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity","volume":"18","author":"Gregersen","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0635","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/archneur.60.12.1721","article-title":"A controlled trial of rotigotine monotherapy in early Parkinson's disease","volume":"60","author":"Group, T. P. S","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0640","series-title":"Encyclopedia of the Neurological Sciences (Second Edition)","first-page":"287","article-title":"Astrocytes","author":"Guo","year":"2014"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0645","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/brain\/awaa090","article-title":"Microglial exosomes facilitate \u03b1-synuclein transmission in Parkinson's disease","volume":"143","author":"Guo","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0650","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.neuroscience.2021.03.022","article-title":"Current developments in cell replacement therapy for Parkinson\u2019s disease","volume":"463","author":"Guo","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0655","doi-asserted-by":"crossref","first-page":"8940","DOI":"10.1523\/JNEUROSCI.0026-12.2012","article-title":"Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing","volume":"32","author":"Hall","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0660","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2019.03.016","article-title":"Immune signaling in neurodegeneration","volume":"50","author":"Hammond","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0665","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/npp.2016.199","article-title":"Inflammation, glutamate, and glia: a trio of trouble in mood disorders","volume":"42","author":"Haroon","year":"2017","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0670","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/brain\/awaa457","article-title":"Glial cells and adaptive immunity in frontotemporal dementia with tau pathology","volume":"144","author":"Hartnell","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0675","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1093\/brain\/awp293","article-title":"Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease","volume":"132","author":"Hattingen","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0680","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.410300409","article-title":"Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease","volume":"30","author":"Hattori","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0685","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6137521","article-title":"Oxidative stress and neuroinflammation potentiate each other to promote progression of dopamine neurodegeneration","volume":"2020","author":"He","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.111024","article-title":"Advances in animal models of Parkinson's disease","volume":"215","author":"He","year":"2024","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0695","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0006-8993(01)02681-6","article-title":"Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum","volume":"909","author":"He","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0700","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0705","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1471-4159.1995.65010192.x","article-title":"Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release","volume":"65","author":"Heeringa","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0710","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/glia.23908","article-title":"Astrocytes are necessary for blood-brain barrier maintenance in the adult mouse brain","volume":"69","author":"Heithoff","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0715","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/nbdi.2000.0289","article-title":"The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system","volume":"7","author":"Herrera","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0720","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00702-004-0121-3","article-title":"Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons","volume":"112","author":"Herrera","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0725","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41531-018-0061-5","article-title":"NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson\u2019s disease","volume":"4","author":"von Herrmann","year":"2018","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0730","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2147\/JPR.S32143","article-title":"Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series","volume":"5","author":"Hesselink","year":"2012","journal-title":"J. Pain Res."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2025.578716_bb0735","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson\u2019s disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0740","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbi.2012.10.001","article-title":"Further characterisation of the LPS model of Parkinson\u2019s disease: a comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat","volume":"27","author":"Hoban","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0745","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0750","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.redox.2017.09.017","article-title":"Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway","volume":"14","author":"Hou","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0755","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1161\/STROKEAHA.112.659656","article-title":"Microglia\/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia","volume":"43","author":"Hu","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0760","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/BST20210819","article-title":"Molecular regulation of autophagosome formation","volume":"50","author":"Hu","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0765","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/cns.13569","article-title":"Peripheral inflammation and blood\u2013brain barrier disruption: effects and mechanisms","volume":"27","author":"Huang","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0770","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fphar.2012.00033","article-title":"Aspects of innate immunity and Parkinson\u2019s disease","volume":"3","author":"Huang","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578447","article-title":"Elevated C1s\/C1-INH in serum and plasma of myasthenia gravis patients","volume":"396","author":"Huang","year":"2024","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0780","first-page":"7","article-title":"Inhibitory effect of thiacremonone on MPTP-induced dopaminergic neurodegeneration through inhibition of p38 activation","author":"Hwang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0785","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.parkreldis.2012.07.002","article-title":"In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease","volume":"19","author":"Iannaccone","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0790","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.alit.2022.07.006","article-title":"Control of immunity and allergy by steroid hormones","volume":"71","author":"Ikuta","year":"2022","journal-title":"Allergol. Int."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0795","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0800","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/157015907780866893","article-title":"Parkinson\u2019s disease: genetics and beyond","volume":"5","author":"Inamdar","year":"2007","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0805","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","article-title":"Glutamate-induced excitotoxicity in Parkinson\u2019s disease: the role of glial cells","volume":"144","author":"Iovino","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0810","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0306-4522(01)00562-0","article-title":"Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration","volume":"110","author":"Iravani","year":"2002","journal-title":"Neurosci"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0815","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in Parkinson's disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0820","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0825","series-title":"Progress in Molecular Biology and Translational Science","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/bs.pmbts.2019.04.005","article-title":"Chapter 7 - Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer\u2019s disease","author":"Janssen","year":"2019"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0830","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.3233\/JPD-223338","article-title":"Inflammasome activation in Parkinson\u2019s disease","volume":"12","author":"Jewell","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0835","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3389\/fnagi.2018.00378","article-title":"A critical role of autophagy in regulating microglia polarization in neurodegeneration","volume":"10","author":"Jin","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0840","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/cea.12292","article-title":"Activation states of blood eosinophils in asthma","volume":"44","author":"Johansson","year":"2014","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0845","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ana.23626","article-title":"Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain","volume":"72","author":"Kaindl","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0850","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in Parkinson\u2019s disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0860","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3233\/JPD-130250","article-title":"The role of innate and adaptive immunity in Parkinson\u2019s disease","volume":"3","author":"Kannarkat","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0865","doi-asserted-by":"crossref","first-page":"9088","DOI":"10.3390\/ijms24109088","article-title":"Parkinson\u2019s disease: exploring different animal model systems","volume":"24","author":"Khan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105313","article-title":"Complement system changes in blood in Parkinson's disease and progressive Supranuclear Palsy\/Corticobasal Syndrome","volume":"108","author":"Khosousi","year":"2023","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0875","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/jnr.490360508","article-title":"Glutamate neurotoxicity in mesencephalic dopaminergic neurons in culture","volume":"36","author":"Kikuchi","year":"1993","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0880","article-title":"Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0885","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5607\/en.2016.25.3.113","article-title":"Non-cell-autonomous neurotoxicity of \u03b1-synuclein through microglial toll-like receptor 2","volume":"25","author":"Kim","year":"2016","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-023-08769-8","article-title":"Amelioration of astrocyte-mediated neuroinflammation by EI-16004 confers neuroprotection in an MPTP-induced Parkinson\u2019s disease model","volume":"26","author":"Kim","year":"2024","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0895","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.stem.2023.08.014","article-title":"Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson&#x2019;s disease, STEM-PD","volume":"30","author":"Kirkeby","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0900","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson's disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0905","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00415-025-13000-8","article-title":"Could adaptive deep brain stimulation treat freezing of gait in Parkinson\u2019s disease?","volume":"272","author":"Klocke","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0910","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0162-3109(98)00022-8","article-title":"Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"39","author":"Kohutnicka","year":"1998","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0915","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-5-8","article-title":"Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson\u2019s disease","volume":"5","author":"Koprich","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0920","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.20369","article-title":"Blood-brain barrier dysfunction in parkinsonian midbrain in vivo","volume":"57","author":"Kortekaas","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0925","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/abbi.1995.1276","article-title":"Antioxidant action of neuromelanin: The mechanism of inhibitory effect on lipid peroxidation","volume":"319","author":"Korytowski","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0930","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00702-012-0842-7","article-title":"Autoimmunity, dendritic cells and relevance for Parkinson\u2019s disease","volume":"120","author":"Koutsilieri","year":"2013","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0935","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cyto.2012.07.030","article-title":"Inflammatory cytokines and NT-proCNP in Parkinson's disease patients","volume":"60","author":"Koziorowski","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176819","article-title":"Experimental models of Parkinson's disease: challenges and opportunities","volume":"980","author":"Lal","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0945","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/glia.24109","article-title":"Astrocytic VEGFA: an essential mediator in blood-brain-barrier disruption in Parkinson\u2019s disease","volume":"70","author":"Lan","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0950","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuro.2024.06.017","article-title":"Neuroprotective efficacy of the glucocorticoid receptor modulator PT150 in the rotenone mouse model of Parkinson\u2019s disease","volume":"103","author":"Latham","year":"2024","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0955","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.parkreldis.2020.11.011","article-title":"Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging","volume":"82","author":"Lavisse","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0960","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1523\/JNEUROSCI.19-04-01484.1999","article-title":"Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine","volume":"19","author":"LaVoie","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0965","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/nm1314","article-title":"Dopamine covalently modifies and functionally inactivates parkin","volume":"11","author":"LaVoie","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0970","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","article-title":"MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration","volume":"26","author":"Lee","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0975","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1742-2094-9-271","article-title":"PINK1 positively regulates IL-1beta-mediated signaling through Tollip and IRAK1 modulation","volume":"9","author":"Lee","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0980","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1212\/WNL.0b013e3182749f28","article-title":"Traumatic brain injury, paraquat exposure, and their relationship to Parkinson disease","volume":"79","author":"Lee","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2025.578716_bb0985","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1471-4159.2005.03404.x","article-title":"Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells","volume":"95","author":"Li","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0990","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.736310","article-title":"Microglial phenotypic transition: Signaling pathways and influencing modulators involved in regulation in central nervous system diseases","volume":"15","author":"Li","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb0995","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nri.2017.125","article-title":"Microglia and macrophages in brain homeostasis and disease","volume":"18","author":"Li","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1000","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","article-title":"NF\u03baB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer\u2019s disease","volume":"85","author":"Lian","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12974-023-02776-z","article-title":"PARK7\/DJ-1 in microglia: implications in Parkinson\u2019s disease and relevance as a therapeutic target","volume":"20","author":"Lind-Holm Mogensen","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1015","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ana.23951","article-title":"Adaptive deep brain stimulation in advanced Parkinson disease","volume":"74","author":"Little","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-3565(24)38877-9","article-title":"Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide","volume":"295","author":"Liu","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1025","article-title":"Lipopolysaccharide animal models for Parkinson's disease","volume":"2011","author":"Liu","year":"2011","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-3-29","article-title":"Complement activation in the Parkinson\u2019s disease substantia nigra: an immunocytochemical study","volume":"3","author":"Loeffler","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1035","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","article-title":"Association between early-onset Parkinson\u2019s disease and mutations in the parkin gene","volume":"342","author":"Lucking","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1040","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","article-title":"\u03b1-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease","volume":"9","author":"Ludtmann","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1045","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","article-title":"Microglial activation and chronic neurodegeneration","volume":"7","author":"Lull","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1050","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00011-022-01676-x","article-title":"Role of \u03b1-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson\u2019s disease","volume":"72","author":"Lv","year":"2023","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1055","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1523\/JNEUROSCI.1781-07.2007","article-title":"CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4","volume":"27","author":"Lyons","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1060","series-title":"Practical Surgical Neuropathology: A Diagnostic Approach (Second Edition)","first-page":"659","article-title":"27 - biopsy pathology of neurodegenerative disorders in adults","author":"Ma","year":"2018"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1065","article-title":"Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson\u2032s disease incidence","volume":"2011","author":"Machado","year":"2011","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1070","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.neurobiolaging.2007.11.020","article-title":"Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: neuroimmune sensitization of neurodegeneration","volume":"30","author":"Mangano","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417146","article-title":"Astrocyte involvement in blood\u2013brain barrier function: a critical update highlighting novel, complex, neurovascular interactions","volume":"24","author":"Manu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1080","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41418-022-01034-8","article-title":"Mitochondria in the line of fire","volume":"29","author":"Marchi","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13223-018-0278-1","article-title":"An introduction to immunology and immunopathology","volume":"14","author":"Marshall","year":"2018","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1090","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.tins.2022.08.001","article-title":"How the immune system shapes neurodegenerative diseases","volume":"45","author":"Mason","year":"2022","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuron.2017.07.005","article-title":"Location, location, location: microglia are where they live","volume":"95","author":"McCarthy","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","article-title":"Environmental risk factors and Parkinson\u2019s disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat","volume":"10","author":"McCormack","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1474-4422(23)00378-2","article-title":"Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial","volume":"23","author":"McGarry","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1110","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson\u2019s disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1115","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1120","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","article-title":"Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration","volume":"54","author":"McGeer","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1125","first-page":"22","article-title":"Unilateral intrastriatal 6-hydroxydopamine lesion in mice: a closer look into non-motor phenotype and glial response","author":"Mendes-Pinheiro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1130","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.21-11-j0003.2001","article-title":"Free 3-nitrotyrosine causes striatal neurodegeneration in vivo","volume":"21","author":"Mihm","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.expneurol.2005.10.034","article-title":"Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys","volume":"197","author":"Miklossy","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s004010000284","article-title":"Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude","volume":"101","author":"Mittelbronn","year":"2001","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1145","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122623","article-title":"Neuron-astrocyte interactions in Parkinson's disease","volume":"9","author":"Miyazaki","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1150","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1523\/JNEUROSCI.5601-11.2012","article-title":"LRRK2 inhibition attenuates microglial inflammatory responses","volume":"32","author":"Moehle","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02252965","article-title":"Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson's disease. J Neural","volume":"9","author":"Mogi","year":"1995","journal-title":"Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.chemphyslip.2003.10.010","article-title":"Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases","volume":"128","author":"Montine","year":"2004","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1170","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0891-5849(02)00807-9","article-title":"Lipid peroxidation in aging brain and Alzheimer\u2019s disease","volume":"33","author":"Montine","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/antiox10010124","article-title":"The neuromelanin paradox and its dual role in oxidative stress and neurodegeneration","volume":"10","author":"Moreno-Garc\u00eda","year":"2021","journal-title":"Antioxid"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1180","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0167-5699(96)20028-F","article-title":"Expression of complement in the brain: role in health and disease","volume":"17","author":"Morgan","year":"1996","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson\u2019s disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1190","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","article-title":"Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons","volume":"27","author":"Mount","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1195","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/00004647-199611000-00015","article-title":"GABAA receptor activation attenuates excitotoxicity but exacerbates Oxygen\u2014Glucose deprivation-induced neuronal injury in vitro","volume":"16","author":"Muir","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1200","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1365-2249.1998.00727.x","article-title":"Levels of soluble Fc gammaRIII correlate with disease severity in sepsis","volume":"114","author":"Muller Kobold","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1205","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-pathol-011110-130224","article-title":"Mechanisms of leukocyte transendothelial migration","volume":"6","author":"Muller","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/jnc.13409","article-title":"Chronic and progressive Parkinson\u2019s disease MPTP model in adult and aged mice","volume":"136","author":"Mu\u00f1oz-Manchado","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1215","first-page":"15","article-title":"Tyrosine hydroxylase: human isoforms, structure and regulation in physiology and pathology","volume":"30","author":"Nagatsu","year":"1995","journal-title":"Essays Biochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1220","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00702-023-02617-6","article-title":"The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson\u2019s disease","volume":"130","author":"Nagatsu","year":"2023","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1225","first-page":"23","article-title":"Revisiting the role of astrocytic MAOB in Parkinson\u2019s disease","author":"Nam","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1230","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/oem.60.5.378","article-title":"Endotoxin: is it an environmental factor in the cause of Parkinson\u2019s disease?","volume":"60","author":"Niehaus","year":"2003","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1235","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/CS20230513","article-title":"The complement system in neurodegenerative diseases","volume":"138","author":"Nimmo","year":"2024","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1240","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1254\/jphs.09292SC","article-title":"Tumor necrosis factor-\u03b1 mediates the blood\u2013brain barrier dysfunction induced by activated microglia in mouse brain microvascular endothelial cells","volume":"112","author":"Nishioku","year":"2010","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1245","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.639353","article-title":"Microglia-derived interleukin 23: a crucial Cytokine in Alzheimer's disease?","volume":"12","author":"Nitsch","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1250","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.27115","article-title":"Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th Anniversary of the Shaking Palsy","volume":"32","author":"Obeso","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1255","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1038\/s41591-024-03196-z","article-title":"Chronic adaptive deep brain stimulation versus conventional stimulation in Parkinson\u2019s disease: a blinded randomized feasibility trial","volume":"30","author":"Oehrn","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1260","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/mds.26119","article-title":"Levodopa: effect on cell death and the natural history of Parkinson\u2019s disease","volume":"30","author":"Olanow","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1265","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1474-4422(06)70521-X","article-title":"Continuous dopamine-receptor treatment of Parkinson\u2019s disease: scientific rationale and clinical implications","volume":"5","author":"Olanow","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1270","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/861231","article-title":"Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity","volume":"2014","author":"Olmos","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1275","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105022","article-title":"Peripheral inflammation induces long-term changes in tyrosine hydroxylase activation in the substantia nigra","volume":"146","author":"Ong","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1280","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s12035-020-02198-5","article-title":"NLRP3 inflammasome inhibition prevents \u03b1-Synuclein pathology by relieving autophagy dysfunction in chronic MPTP-treated NLRP3 knockout Mice","volume":"58","author":"Ou","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1285","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson's disease","volume":"57","author":"Ouchi","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1290","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-8-9","article-title":"CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson\u2019s disease","volume":"8","author":"Pabon","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1295","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease","volume":"44","author":"Paisan-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1300","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/humc.2018.081","article-title":"Long-term follow-up of a phase I\/II study of ProSavin, a lentiviral vector gene therapy for Parkinson\u2019s disease","volume":"29","author":"Palfi","year":"2018","journal-title":"Human Gene Thera. Clin. Develop."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","article-title":"The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s disease","volume":"8","author":"Pang","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1310","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1084\/jem.20182191","article-title":"Fyn kinase regulates misfolded \u03b1-synuclein uptake and NLRP3 inflammasome activation in microglia","volume":"216","author":"Panicker","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1315","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2020.34.s1.01881","article-title":"NLRP3 inflammasome activation in dopamine neurons contributes to neurodegeneration in Parkinson\u2019s Disease","volume":"34","author":"Panicker","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2022.05.009","article-title":"Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson\u2019s disease","volume":"110","author":"Panicker","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1325","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy. 1817","volume":"14","author":"Parkinson","year":"2002","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1330","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2013.10","article-title":"Cerebrospinal fluid biomarkers in Parkinson disease","volume":"9","author":"Parnetti","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-019-00104-z","article-title":"Differential effects of LPS and 6-OHDA on microglia's morphology in rats: implications for inflammatory model of Parkinson's disease","volume":"37","author":"Parra","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1340","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","article-title":"Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration","volume":"19","author":"Patani","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1345","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/antiox13020240","article-title":"Mitochondria dysfunction and neuroinflammation in neurodegeneration: who comes first?","volume":"13","author":"Peggion","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1350","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.768108","article-title":"Blood-brain barrier disruption by lipopolysaccharide and sepsis-associated encephalopathy","volume":"11","author":"Peng","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1355","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2360872","article-title":"Oxidative stress in Parkinson\u2019s disease:p benefits of antioxidant supplementation","volume":"2020","author":"Perc\u00e1rio","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1360","first-page":"1","article-title":"Immune system and Parkinson\u2019s Disease","volume":"8","author":"Perez","year":"2016","journal-title":"Arch. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1365","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/brain\/awg136","article-title":"Parkin mutations are frequent in patients with isolated early-onset parkinsonism","volume":"126","author":"Periquet","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1370","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","article-title":"Microglial priming in neurodegenerative disease","volume":"10","author":"Perry","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1375","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1742-2094-9-188","article-title":"Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease","volume":"9","author":"Pisani","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1380","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.tins.2020.10.002","article-title":"Microglial phagocytosis: a disease-associated process emerging from Alzheimer\u2019s disease genetics","volume":"43","author":"Podle\u015bny-Drabiniok","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1385","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mds.26078","article-title":"Novel formulations and modes of delivery of levodopa","volume":"30","author":"Poewe","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1390","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1395","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163359","article-title":"Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson's disease","volume":"9","author":"Pons-Espinal","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1400","doi-asserted-by":"crossref","first-page":"15879","DOI":"10.1523\/JNEUROSCI.0530-13.2013","article-title":"TNF-\u03b1 downregulates inhibitory neurotransmission through protein phosphatase 1-dependent trafficking of GABA(A) receptors","volume":"33","author":"Pribiag","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1405","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1410","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1046\/j.1471-4159.1999.0722215.x","article-title":"Murine microglial cells produce and respond to interleukin-18","volume":"72","author":"Prinz","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1415","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2006.10.008","article-title":"Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration","volume":"25","author":"Purisai","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1420","first-page":"367","article-title":"Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin 10","author":"Qian","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1425","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1103416","article-title":"Microglia activation in central nervous system disorders: A review of recent mechanistic investigations and development efforts","volume":"14","author":"Qin","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1430","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1435","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.bbi.2020.10.010","article-title":"Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson's disease","volume":"91","author":"Qin","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1440","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1445","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.fmre.2023.02.025","article-title":"Allogenic microglia replacement: A novel therapeutic strategy for neurological disorders","volume":"4","author":"Rao","year":"2024","journal-title":"Fundam. Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1450","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fnins.2016.00193","article-title":"The enemy within: Innate surveillance-mediated cell death, the common mechanism of neurodegenerative disease","volume":"10","author":"Richards","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1455","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2012.04.014","article-title":"Astrocyte-derived GDNF is a potent inhibitor of microglial activation","volume":"47","author":"Rocha","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1460","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.3390\/ijms23052793","article-title":"Microglial activation damages dopaminergic neurons through MMP-2\/-9-mediated increase of blood-brain barrier permeability in a Parkinson\u2019s disease mouse model","volume":"23","author":"Ruan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1465","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1038\/s41467-023-39038-8","article-title":"The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson\u2019s disease","volume":"14","author":"de Rus Jacquet","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1470","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12974-015-0449-7","article-title":"Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-\u03baB p50 signaling in cultured microglia cells","volume":"12","author":"Russo","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1475","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cell.2009.01.038","article-title":"A Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death","volume":"137","author":"Saijo","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1480","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.3233\/JPD-223278","article-title":"Therapeutic strategies for immune transformation in Parkinson\u2019s disease","volume":"12","author":"Saleh","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1485","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/11316780-000000000-00000","article-title":"NSAID use and the risk of Parkinson\u2019s disease: systematic review and meta-analysis of observational studies","volume":"26","author":"Samii","year":"2009","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1490","article-title":"A review of diagnostic imaging approaches to assessing Parkinson\u2019s disease","volume":"6","author":"Samson","year":"2022","journal-title":"BDS"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1495","first-page":"17","article-title":"New insights in animal models of neurotoxicity-induced neurodegeneration","author":"Sanfeliu","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1500","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/jnr.24513","article-title":"Enhanced mitochondrial inhibition by 3,4-dihydroxyphenyl-acetaldehyde (DOPAL)-oligomerized alpha-synuclein","volume":"97","author":"Sarafian","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1505","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jamaneurol.2013.114","article-title":"Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism","volume":"70","author":"Savica","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1510","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","article-title":"Mitochondria in the aetiology and pathogenesis of Parkinson\u2019s disease","volume":"7","author":"Schapira","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1515","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2165\/11596310-000000000-00000","article-title":"Monoamine oxidase B inhibitors for the treatment of Parkinson\u2019s disease: a review of symptomatic and potential disease-modifying effects","volume":"25","author":"Schapira","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1520","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1525","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.09.007","article-title":"Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes","volume":"184","author":"Scheiblich","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1530","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2024.06.029","article-title":"Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes","volume":"112","author":"Scheiblich","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1535","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00629","article-title":"Deep brain stimulation is well tolerated and effective following ProSavin&#xae; gene therapy for Parkinson's disease","author":"Senova","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1540","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104524","article-title":"Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson\u2019s disease","volume":"130","author":"Shehadeh","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1545","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1007\/s00018-017-2549-2","article-title":"The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease","volume":"74","author":"Shen","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1550","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mds.25249","article-title":"The genetics of Parkinson\u2019s disease: progress and therapeutic implications","volume":"28","author":"Singleton","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1555","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27175481","article-title":"Lipopolysaccharide-induced model of neuroinflammation: Mechanisms of action, research application and future directions for its use","volume":"27","author":"Skrzypczak-Wiercioch","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1560","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s12264-021-00651-6","article-title":"Alpha-synuclein handling by microglia: Activating, combating, and worsening","volume":"37","author":"Song","year":"2021","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1565","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01345245","article-title":"Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism","volume":"14","author":"Sonsalla","year":"1998","journal-title":"Amino Acids"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1570","doi-asserted-by":"crossref","first-page":"R506","DOI":"10.1016\/j.cub.2008.04.047","article-title":"Microglia","volume":"18","author":"Soulet","year":"2008","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1575","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.4103\/1673-5374.215250","article-title":"Interleukin 4-induced neuroprotection and regulation of microglia activation as a therapeutic approach in the MPTP model of Parkinson's disease","volume":"12","author":"Spittau","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1580","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/genetics\/153.1.361","article-title":"The catecholamines up (Catsup) protein of Drosophila melanogaster functions as a negative regulator of tyrosine hydroxylase activity","volume":"153","author":"Stathakis","year":"1999","journal-title":"Genetics"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1585","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.3233\/JPD-223237","article-title":"Microglia in Parkinson's Disease","volume":"12","author":"Stefanova","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1590","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/14728222.2023.2177532","article-title":"The case for complement component 5 as a target in neurodegenerative disease","volume":"27","author":"Stennett","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1595","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1089\/ars.2009.2460","article-title":"Innate and adaptive immunity for the pathobiology of Parkinson\u2019s disease","volume":"11","author":"Stone","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1600","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","article-title":"Synuclein activates microglia in a model of Parkinson\u2019s disease","volume":"29","author":"Su","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1605","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","article-title":"Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles","volume":"97","author":"Sulzer","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1610","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10571-009-9446-7","article-title":"Lipopolysaccharide-activated microglia induce dysfunction of the blood-brain barrier in rat microvascular endothelial cells co-cultured with microglia","volume":"30","author":"Sumi","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1615","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1620","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system - associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1625","first-page":"21","article-title":"New insights into immune-mediated mechanisms in Parkinson\u2019s disease","author":"Tan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1630","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0304-3940(92)90071-E","article-title":"Tumor necrosis factor alters synaptic transmission in rat hippocampal slices","volume":"146","author":"Tancredi","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1635","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1640","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1645","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/glia.22657","article-title":"LPS and IL-1 differentially activate mouse and human astrocytes: role of CD14","volume":"62","author":"Tarassishin","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1650","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuint.2012.12.016","article-title":"Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson\u2019s disease","volume":"62","author":"Taylor","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1655","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s12149-016-1099-2","article-title":"Extrastriatal spreading of microglial activation in Parkinson\u2019s disease: a positron emission tomography study","volume":"30","author":"Terada","year":"2016","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1660","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41531-024-00640-2","article-title":"Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson\u2019s disease mouse model","volume":"10","author":"Thi Lai","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1665","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41240-z","article-title":"Viral-like TLR3 induction of cytokine networks and alpha-synuclein are reduced by complement C3 blockade in mouse brain","volume":"13","author":"Thomas","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1670","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.arr.2014.11.003","article-title":"DAMPs and neurodegeneration","volume":"24","author":"Thundyil","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1675","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.3233\/JPD-230264","article-title":"The role of diet in Parkinson\u2019s disease","volume":"14","author":"Tosefsky","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023660","article-title":"Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B","volume":"6","author":"Tran","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1685","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3389\/fneur.2018.00860","article-title":"Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson\u2019s Disease","volume":"9","author":"Troncoso-Escudero","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1690","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/jnc.12633","article-title":"DJ-1 deficiency triggers microglia sensitivity to dopamine toward a pro-inflammatory phenotype that is attenuated by rasagiline","volume":"129","author":"Trudler","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1695","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025847118","article-title":"Soluble \u03b1-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia","volume":"118","author":"Trudler","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1700","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13522","article-title":"\u03b1-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson\u2019s disease","volume":"20","author":"Tu","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1705","article-title":"The Endotoxin-induced neuroinflammation model of Parkinson\u2032s disease","volume":"2011","author":"Tufekci","year":"2011","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1710","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mds.10305","article-title":"Systematic review of incidence studies of Parkinson\u2019s disease","volume":"18","author":"Twelves","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1715","first-page":"24","article-title":"LPS triggers acute neuroinflammation and parkinsonism involving NLRP3 inflammasome pathway and mitochondrial CI dysfunction in the rat","author":"Valenzuela-Arzeta","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1720","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1725","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nbd.2009.03.004","article-title":"Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells","volume":"34","author":"Van Laar","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1730","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13302-6","article-title":"Lipopolysaccharide enters the rat brain by a lipoprotein-mediated transport mechanism in physiological conditions","volume":"7","author":"Vargas-Caraveo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1735","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/jnc.15432","article-title":"Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo","volume":"158","author":"Vecchio","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1740","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/exnr.1999.7199","article-title":"Cytokines associated with amyloid plaques in Alzheimer\u2019s disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor","volume":"160","author":"Veerhuis","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1745","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.molimm.2011.04.003","article-title":"Complement in the brain","volume":"48","author":"Veerhuis","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1750","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12974-014-0228-x","article-title":"Neuromelanin activates proinflammatory microglia through a caspase-8-dependent mechanism","volume":"12","author":"Viceconte","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1755","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","article-title":"VPS35 mutations in Parkinson disease","volume":"89","author":"Vilarino-Guell","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1760","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/hmg\/ddt570","article-title":"DNAJC13 mutations in Parkinson disease","volume":"23","author":"Vilarino-Guell","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1765","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2967\/jnumed.114.141713","article-title":"Imaging microglial activation with TSPO PET: lighting up neurologic diseases?","volume":"57","author":"Vivash","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1770","first-page":"11","article-title":"Inflammasomes in neuroinflammatory and neurodegenerative diseases","author":"Voet","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1775","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1096\/fj.08-125153","article-title":"Regulation of astrocyte inflammatory responses by the Parkinson\u2019s disease-associated gene DJ-1","volume":"23","author":"Waak","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1780","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/01.wnr.0000215769.71657.65","article-title":"Expression levels of vascular endothelial growth factor and its receptors in Parkinson's disease","volume":"17","author":"Wada","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1785","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson's disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1790","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12264-022-00957-z","article-title":"Association of glial activation and \u03b1-synuclein pathology in Parkinson\u2019s disease","volume":"39","author":"Wang","year":"2023","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1795","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0022-3565(24)35318-2","article-title":"Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons","volume":"292","author":"Wang","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1800","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson\u2019s disease","volume":"67","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1805","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3390\/cells12192336","article-title":"Astrocytes in Parkinson\u2019s disease: Ffrom role to possible intervention","volume":"12","author":"Wang","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1810","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1073\/pnas.1610099113","article-title":"Caspase-1 causes truncation and aggregation of the Parkinson\u2019s disease-associated protein \u03b1-synuclein","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1815","first-page":"931","article-title":"\u03b1-synuclein promotes progression of Parkinson's disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome","volume":"19","author":"Wang","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1820","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ajpath.2011.01.006","article-title":"Complement 3 and factor H in human cerebrospinal fluid in Parkinson\u2019s disease, Alzheimer\u2019s disease, and multiple-system atrophy","volume":"178","author":"Wang","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1825","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.expneurol.2012.06.025","article-title":"Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein","volume":"237","author":"Watson","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1830","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.cellbio.21.122303.115827","article-title":"Recognition and signaling by toll-like receptors","volume":"22","author":"West","year":"2006","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1835","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1007\/s11064-020-02959-7","article-title":"Astrocyte diversity: current insights and future directions","volume":"45","author":"Westergard","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1840","author":"WHO"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1845","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.baga.2011.05.001","article-title":"Deep-brain stimulation for basal ganglia disorders","volume":"1","author":"Wichmann","year":"2011","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1850","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105920","article-title":"Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson\u2019s disease and neurodegeneration with brain iron accumulation disorders","volume":"175","author":"Wise","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1855","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081101","article-title":"LRRK2 targeting strategies as potential treatment of Parkinson\u2019s disease","volume":"11","author":"Wojewska","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1860","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1865","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.ajpath.2020.02.006","article-title":"Complement membrane attack complex: new roles, mechanisms of action, and therapeutic targets","volume":"190","author":"Xie","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1870","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00311389","article-title":"Vimentin immunoreactivity in normal and pathological human brain tissue","volume":"84","author":"Yamada","year":"1992","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1875","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00427222","article-title":"Lewy bodies in Parkinson\u2019s disease are recognized by antibodies to complement proteins","volume":"84","author":"Yamada","year":"1992","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1880","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.3233\/JPD-230393","article-title":"Experimental animal models of prodromal Parkinson\u2019s disease","volume":"14","author":"Yamakado","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1885","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13834","article-title":"Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease","volume":"22","author":"Yan","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1890","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113018","article-title":"A time-course study of microglial activation and dopaminergic neuron loss in the substantia nigra of mice with paraquat-induced Parkinson's disease","volume":"164","author":"Yang","year":"2022","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1895","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.23571","article-title":"Neuroinflammation in the central nervous system: symphony of glial cells","volume":"67","author":"Yang","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1900","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12974-024-03234-0","article-title":"Exercise training upregulates CD55 to suppress complement-mediated synaptic phagocytosis in Parkinson\u2019s disease","volume":"21","author":"Yao","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1905","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102032","article-title":"Metabolic reprogramming and polarization of microglia in Parkinson\u2019s disease: Role of inflammasome and iron","volume":"90","author":"Yu","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1910","article-title":"Role of NLRP3 in Parkinson's disease: Specific activation especially in dopaminergic neurons","volume":"10","author":"Yu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1915","doi-asserted-by":"crossref","first-page":"19855","DOI":"10.18632\/oncotarget.15774","article-title":"M2 microglia promotes neurogenesis and oligodendrogenesis from neural stem\/progenitor cells via the PPAR\u03b3 signaling pathway","volume":"8","author":"Yuan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1920","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1124\/mol.106.024703","article-title":"A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition","volume":"70","author":"Zafar","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1925","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0925-4439(95)00058-C","article-title":"The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems","volume":"1271","author":"Zar\u0229ba","year":"1995","journal-title":"BBA Mol. Basis Dis."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1930","first-page":"414","article-title":"Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour","volume":"54","author":"Zecca","year":"2001","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1935","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1471-4159.2008.05541.x","article-title":"Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson\u2019s disease","volume":"106","author":"Zecca","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1940","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12974-020-02065-z","article-title":"Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson\u2019s disease model","volume":"18","author":"Zhang","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1945","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12264-022-01013-6","article-title":"Novel microglia-based therapeutic approaches to neurodegenerative disorders","volume":"39","author":"Zhang","year":"2023","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1950","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: A process leading to disease progression in Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1955","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12640-009-9140-z","article-title":"Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2011","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1960","first-page":"1","article-title":"Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death","volume":"5","author":"Zhang","year":"2013","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"10.1016\/j.jneuroim.2025.578716_bb1965","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbi.2024.03.038","article-title":"Pyroptosis-mediator GSDMD promotes Parkinson\u2019s disease pathology via microglial activation and dopaminergic neuronal death","volume":"119","author":"Zhang","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1970","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105094","article-title":"Activated microglia facilitate the transmission of \u03b1-synuclein in Parkinson's disease","volume":"148","author":"Zheng","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1975","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1007\/s12035-023-03393-w","article-title":"Complement C3 enhances LPS-elicited neuroinflammation and neurodegeneration Via the Mac1\/NOX2 pathway","volume":"60","author":"Zhou","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1980","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jnc.13111","article-title":"TGF\u03b21 inhibits IFN\u03b3-mediated microglia activation and protects mDA neurons from IFN\u03b3-driven neurotoxicity","volume":"134","author":"Zhou","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1985","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","article-title":"MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease","volume":"11","author":"Zhou","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1990","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/10715760902801533","article-title":"Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones","volume":"43","author":"Zhou","year":"2009","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.jneuroim.2025.578716_bb1995","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00018-022-04574-x","article-title":"The role of tyrosine hydroxylase-dopamine pathway in Parkinson\u2019s disease pathogenesis","volume":"79","author":"Zhou","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb2000","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1039780","article-title":"The role of microglial autophagy in Parkinson's disease","volume":"14","author":"Zhu","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578716_bb2005","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","article-title":"A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease","volume":"89","author":"Zimprich","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jneuroim.2025.578716_bb2010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/iub.2654","article-title":"Neuromelanins in brain aging and Parkinson\u2019s disease: Synthesis, structure, neuroinflammatory, and neurodegenerative role","volume":"75","author":"Zucca","year":"2023","journal-title":"IUBMB Life"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825001973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825001973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:33:08Z","timestamp":1782261188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572825001973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":402,"alternative-id":["S0165572825001973"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578716","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunity in Parkinson's disease \u2013 The role of innate responses","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578716"}}